Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Gynecology

The Biology of MRKH: Understanding Your Body’s Blueprint

At a Glance

Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome occurs when the Müllerian ducts fail to develop properly, resulting in an absent or underdeveloped uterus and upper vagina, though ovaries remain healthy. A pelvic MRI and karyotype blood test are essential to confirm the diagnosis and determine the type.

Understanding the biology behind your diagnosis can help demystify what is happening in your body. MRKH is not a disease that needs to be “cured,” but rather a different way the body developed before birth.

The Embryology of MRKH

In the very early stages of fetal development (usually between the 5th and 12th week of pregnancy), two tubes called Müllerian ducts (or paramesonephric ducts) form the foundation of the female reproductive system [1]. In a typical development, these ducts grow, fuse together, and become the uterus, cervix, and the upper two-thirds of the vagina [2].

In MRKH, these ducts fail to develop or fuse properly [3]. This is why the uterus is either absent or exists only as small, non-functional “horns” of tissue [4]. However, because the ovaries and the lower part of the vagina develop from different biological building blocks, they are usually present and healthy [3].

MRKH Type 1 vs. Type 2 (MURCS)

Doctors categorize MRKH based on whether the developmental differences affect only the reproductive system or other parts of the body:

  • Type 1 (Isolated): The differences are limited to the uterus and the upper vagina. The kidneys and skeletal system developed normally [2].
  • Type 2 (MURCS Association): This type involves the reproductive system plus other “extragenital” anomalies [5]. MURCS stands for Müllerian duct aplasia, Renal (kidney) dysplasia, Cervicothoracic Somite (spine) anomalies [6]. Because the kidneys and the reproductive tract develop at the same time and from similar tissues, it is common for a difference in one to be linked to a difference in the other [1].

Getting the Right Diagnosis

Because several conditions can cause someone to not have a period (primary amenorrhea), your medical team must perform specific tests to confirm it is MRKH and not something else.

Comparing Similar Conditions

Condition Karyotype (Chromosomes) Uterus Ovaries Hormones
MRKH 46,XX (Female) Absent Present Normal Female [2][3]
CAIS 46,XY (Typical Male Karyotype) Absent Absent (Testes present) Male-typical Testosterone [7][8]
Swyer Syndrome 46,XY (Typical Male Karyotype) Usually Present Streak (Non-functional) Low Estrogen [9][10]
Imperforate Hymen 46,XX (Female) Present Present Normal Female [11]

Note: Individuals with CAIS or Swyer Syndrome develop typical female physical characteristics despite having a 46,XY karyotype.

  • Complete Androgen Insensitivity Syndrome (CAIS): The body has XY chromosomes but does not respond to testosterone, so it develops female secondary sex characteristics but no uterus [12]. A blood test for testosterone and chromosomes (karyotype) tells the difference [7].
  • Imperforate Hymen or Vaginal Septum: The uterus is there, but the “exit” for period blood is blocked by a thin membrane or wall [13]. An MRI or ultrasound easily shows the presence of a uterus in these cases [11].

Why Pelvic MRI is the “Gold Standard”

While an ultrasound is often the first test, a Pelvic MRI is the most reliable tool for a final diagnosis [3]. MRI provides superior detail, allowing doctors to:

  1. Confirm the absence of the uterus and the presence of ovaries [14].
  2. Identify small uterine “remnants” or “horns” that might cause monthly pain. Functional horns can cause retrograde menstruation into the pelvic cavity, creating a clinical risk for endometriosis [4].
  3. Screen for kidney or spinal issues in the same session, which helps determine if you have Type 1 or Type 2 MRKH [15][5].

Your Diagnostic Checklist

To be certain of an MRKH diagnosis, your care team should complete the following:

  • [ ] Physical/Pelvic Exam: To check the depth of the vaginal dimple [16].
  • [ ] Karyotype Blood Test: To confirm 46,XX chromosomes [3].
  • [ ] Hormone Panel: To check FSH, LH, and Testosterone levels [2][7].
  • [ ] Pelvic MRI: To map the internal anatomy in detail [3].
  • [ ] Renal (Kidney) Ultrasound: To check for missing or misplaced kidneys (if not covered by MRI) [17].
  • [ ] Spine Screening: A baseline screening (such as an X-ray or MRI) should be standard for all newly diagnosed patients to confidently rule out Type 2 MRKH (many spinal anomalies do not cause back pain in adolescence) [5].

Back to Main Guide

Common questions in this guide

What is the difference between MRKH Type 1 and Type 2?
Type 1 MRKH affects only the uterus and upper vagina, while the kidneys and skeletal system develop normally. Type 2, also known as MURCS association, involves these reproductive differences along with kidney or spinal anomalies.
Why do I need a karyotype blood test for an MRKH diagnosis?
A karyotype test checks your chromosomes to confirm a 46,XX female result. This is a crucial step to distinguish MRKH from other genetic conditions that can also cause an absent uterus, such as Complete Androgen Insensitivity Syndrome (CAIS).
Can I still have ovaries if I have MRKH?
Yes, individuals with MRKH typically have healthy, functioning ovaries. This is because the ovaries and the lower part of the vagina develop from completely different biological tissues than the uterus and upper vagina.
Why is a pelvic MRI the gold standard for diagnosing MRKH?
A pelvic MRI provides highly detailed images of your internal anatomy. It is used to confirm the absence of the uterus, locate the ovaries, spot any small uterine remnants that could cause pain, and check for associated kidney or spinal issues.
What are uterine remnants or horns in MRKH?
Uterine horns are small, underdeveloped remnants of uterine tissue that may remain in the pelvis. If these remnants are functional, they can cause monthly pelvic pain and increase the clinical risk for endometriosis.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you explain the exact findings of my pelvic MRI? Were any uterine remnants or 'horns' seen?
  2. 2.Why is a karyotype test necessary if the MRI already showed no uterus?
  3. 3.Does my MRI or ultrasound show both kidneys and are they in the correct location?
  4. 4.Since I have a 46,XX karyotype and normal hormone levels, can you confirm this rules out Swyer syndrome and CAIS?
  5. 5.Based on my tests so far, do I have Type 1 or Type 2 MRKH?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    The Embryological Landscape of Mayer-Rokitansky-Kuster-Hauser Syndrome: Genetics and Environmental Factors.

    Kyei-Barffour I, Margetts M, Vash-Margita A, Pelosi E

    The Yale journal of biology and medicine 2021; (94(4)):657-672.

    PMID: 34970104
  2. 2

    Syndrome Mayer-Rokitansky-Küster-Hauser - uterine and vaginal agenesis: current knowledge and therapeutic options.

    Chmel R, Pastor Z, Mužík M, et al.

    Ceska gynekologie 2019; (84(5)):386-392.

    PMID: 31826637
  3. 3

    Mayer-Rokitansky-Kuster-Hauser Syndrome: From Radiological Diagnosis to Further Challenges-Review and Update.

    Schiau C, Csutak C, Ciurea AI, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(1)) doi:10.3390/diagnostics16010138.

    PMID: 41515635
  4. 4

    Spectrum of MRI Appearance of Mayer-Rokitansky-Kuster-Hauser (MRKH) Syndrome in Primary Amenorrhea Patients.

    Boruah DK, Sanyal S, Gogoi BB, et al.

    Journal of clinical and diagnostic research : JCDR 2017; (11(7)):TC30-TC35 doi:10.7860/JCDR/2017/29016.10317.

    PMID: 28893003
  5. 5

    Mayer-Rokitansky-Küster-Hauser syndrome with inguinal hernia, left renal fusion, and malrotation: a rare case.

    Li C, Yang H, Xiao H, Yan J

    Therapeutic advances in urology 2025; (17()):17562872251398912 doi:10.1177/17562872251398912.

    PMID: 41328177
  6. 6

    Mayer-Rokitansky-Küster-Hauser Syndrome: A Case Report.

    Muthu Kumar A, Menon P, Mane S

    Cureus 2024; (16(8)):e67606 doi:10.7759/cureus.67606.

    PMID: 39185296
  7. 7

    Complexities of complete androgen insensitivity syndrome: insights from a case report and literature review.

    Asanidze E, Kristesashvili J, Asanidze A, et al.

    The Journal of international medical research 2024; (52(11)):3000605241300058 doi:10.1177/03000605241300058.

    PMID: 39600030
  8. 8

    Primary Amenorrhea Due to Anatomical Abnormalities of the Reproductive Tract: Molecular Insight.

    Kapczuk K, Kędzia W

    International journal of molecular sciences 2021; (22(21)) doi:10.3390/ijms222111495.

    PMID: 34768925
  9. 9

    Misdiagnosis of Mullerian agenesis in a patient with 46, XX gonadal dysgenesis: a missed opportunity for prevention of osteoporosis.

    Thewjitcharoen Y, Veerasomboonsin V, Nakasatien S, et al.

    Endocrinology, diabetes & metabolism case reports 2019; (2019()).

    PMID: 31809259
  10. 10

    A rare case of 46,XX gonadal dysgenesis and Mayer-Rokitansky-Kuster-Hauser syndrome.

    Manne S, Veeraabhinav CH, Jetti M, et al.

    Journal of human reproductive sciences 2016; (9(4)):263-266 doi:10.4103/0974-1208.197694.

    PMID: 28216916
  11. 11

    A Female Infant with Rectovestibular Fistula and Imperforate Hymen.

    Khedkar K, Lamture YR, Lohia S, Tayade HA

    Journal of Indian Association of Pediatric Surgeons 2023; (28(2)):177-178 doi:10.4103/jiaps.jiaps_116_22.

    PMID: 37197247
  12. 12

    Uterine Transplantation: Recipient Patient Populations.

    Chung RK, Salari S, Findley J, et al.

    Clinical obstetrics and gynecology 2022; (65(1)):15-23 doi:10.1097/GRF.0000000000000672.

    PMID: 35045021
  13. 13

    Imaging and Diagnostic Challenges in an 11-Year-Old Girl with Vaginal Agenesis: A Case Report.

    Paramita BD, Suhartomo DM, Sukarsa MRA, et al.

    The American journal of case reports 2025; (26()):e944772 doi:10.12659/AJCR.944772.

    PMID: 40059364
  14. 14

    Mayer-Rokitansky-Küster-Hauser syndrome type II: A rare case report.

    Sfar K, Imrani K, Chait F, et al.

    SAGE open medical case reports 2024; (12()):2050313X241265047 doi:10.1177/2050313X241265047.

    PMID: 39071189
  15. 15

    Mayer-Rokitansky-Kuster-Hauser syndrome.

    Novoa CCT, Leite MTC, Sartori MGF

    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 2025; (47()) doi:10.61622/rbgo/2025FPS4.

    PMID: 40406045
  16. 16

    ACOG Committee Opinion No. 728: Müllerian Agenesis: Diagnosis, Management, And Treatment.

    Obstetrics and gynecology 2018; (131(1)):e35-e42 doi:10.1097/AOG.0000000000002458.

    PMID: 29266078
  17. 17

    Living-Donor Kidney Transplant in a Patient With Type B Mayer-Rokitansky-Küster-Hauser Syndrome, Reconstructed Vagina, and Abnormal Pelvic Vessels: A Case Report.

    Campise M, Ferraresso M, Favi E, et al.

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2019; (17(2)):266-268 doi:10.6002/ect.2016.0220.

    PMID: 28540840

This page provides educational information about the biology and diagnosis of MRKH syndrome. It is not a substitute for professional medical advice, diagnosis, or interpretation of your specific imaging and lab results.

Get notified when new evidence is published on Mayer-Rokitansky-Küster-Hauser syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.